In conclusion, our study supports the use of non-invasive parameters such as HA, OELF and ELF scores, or cytokeratin-18 fragments in diagnosing of NASH/fibrosis in those patients with NAFLD. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.